Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4466
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Charles River Laboratories International, Inc. (CRL or ‘the company’) is a full service, early-stage contract research organization. Its core competencies and research model technologies allows it to develop a range of discovery and safety assessment services in both GLP and non-GLP standards. In addition, it provides various services related to clients manufacturing activities. These include basic research services (research animal models, surgical services, genetic testing services, colony management services, health monitoring services), drug discovery and safety assessment services, clinical support services, operations and staffing support services, and manufacturing support services (endotoxin and microbial detection, biologics testing solutions, and avian vaccine services). The company operates in the US, Europe, Japan, Canada and other regions of the world. CRL is headquartered in Wilmington, Massachusetts, the US.

Scope

- Detailed information on Charles River Laboratories International, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Charles River Laboratories International, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Charles River Laboratories International, Inc. including a breakdown and examination of key business segments
- Intelligence on Charles River Laboratories International, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Charles River Laboratories International, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Charles River Laboratories International, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Charles River Laboratories International, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Charles River Laboratories International, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Charles River Laboratories International, Inc.: Company Overview 9
Charles River Laboratories International, Inc.: Overview and Key Facts 9
Charles River Laboratories International, Inc.: Overview 9
Charles River Laboratories International, Inc.: Key Facts 9
Charles River Laboratories International, Inc.: Key Employees 11
Charles River Laboratories International, Inc.: Key Employee Biographies 13
Charles River Laboratories International, Inc.: Major Products and Services 20
Charles River Laboratories International, Inc.: Company History 21
Charles River Laboratories International, Inc.: Management Statement 26
Charles River Laboratories International, Inc.: Locations and Subsidiaries 30
Charles River Laboratories International, Inc.: Key Competitors 31
Charles River Laboratories International, Inc.: Company Analysis 32
Charles River Laboratories International, Inc.: Business Description 32
Charles River Laboratories International, Inc.: SWOT Analysis 34
Charles River Laboratories International, Inc.: SWOT Overview 34
Charles River Laboratories International, Inc.: Strengths 34
Charles River Laboratories International, Inc.: Weaknesses 35
Charles River Laboratories International, Inc.: Opportunities 35
Charles River Laboratories International, Inc.: Threats 38
Charles River Laboratories International, Inc.: Corporate Financial Deals Activity 40
Charles River Laboratories International, Inc.: Financial Deals Overview 40
Charles River Laboratories International, Inc.: Targets and Partners 42
Charles River Laboratories International, Inc.: Top Deals 2014 – 2018YTD* 44
Charles River Laboratories International, Inc.: Advisors 45
Charles River Laboratories International, Inc.: Top Legal Advisors 45
Charles River Laboratories International, Inc.: Top Financial Advisors 45
Charles River Laboratories International, Inc.: Mergers and Acquisitions 46
Charles River Laboratories International, Inc.: Corporate Venturing 47
Charles River Laboratories International, Inc.: Capital Raising 48
Charles River Laboratories International, Inc.: Partnership 49
Charles River Laboratories International, Inc.: Divestments 50
Charles River Laboratories International, Inc.: Recent Developments 51
Charles River Laboratories International, Inc.: News and Events Summary 51
Charles River Laboratories International, Inc.: Business Expansion 56
Charles River Laboratories International, Inc.: Contracts 57
Charles River Laboratories International, Inc.: Corporate Governance 58
Charles River Laboratories International, Inc.: Financial Performance 58
Charles River Laboratories International, Inc.: Market Developments 58
Charles River Laboratories International, Inc.: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Charles River Laboratories International, Inc.: Key Facts
Table 2: Charles River Laboratories International, Inc.: Key Employees
Table 3: Charles River Laboratories International, Inc.: Locations and Subsidiaries
Table 4: Charles River Laboratories International, Inc.: Key Competitors
Table 5: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Table 7: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Charles River Laboratories International, Inc.: Targets and Partners
Table 10: Charles River Laboratories International, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Charles River Laboratories International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Charles River Laboratories International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Charles River Laboratories International, Inc.: News and Events Summary
Table 23: Charles River Laboratories International, Inc.: Business Expansion
Table 24: Charles River Laboratories International, Inc.: Contracts
Table 25: Charles River Laboratories International, Inc.: Corporate Governance
Table 26: Charles River Laboratories International, Inc.: Financial Performance
Table 27: Charles River Laboratories International, Inc.: Market Developments
Table 28: Charles River Laboratories International, Inc.: Strategy and Operations

List of Figures
Figure 1: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Habib Insurance Co Ltd (HICL):企業の財務・戦略的SWOT分析
    Habib Insurance Co Ltd (HICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Heineken Malaysia Berhad:企業の戦略・SWOT・財務情報
    Heineken Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Heineken Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Humana Inc.:企業のM&A・事業提携・投資動向
    Humana Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Humana Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Biglari Holdings Inc.:戦略・SWOT・企業財務分析
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Norwegian Cruise Line Holdings Ltd. (NCLH):企業の財務・戦略的SWOT分析
    Norwegian Cruise Line Holdings Ltd. (NCLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報
    Summary Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotid …
  • YTL Power International Berhad:発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Scope Metals Group Ltd:企業の戦略・SWOT・財務情報
    Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vericel Corp (VCEL)-製薬・医療分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Damco International B.V.
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cypress Energy Partners LP (CELP):企業の財務・戦略的SWOT分析
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • Gradalis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer. Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, br …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • Ship Finance International Ltd (SFL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ship Finance International Ltd (Ship Finance International) is a provider of bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible dry bulk carriers and drilling rigs, among others. It also opera …
  • Ultra Electronics 3Phoenix, Inc.:企業の戦略・SWOT・財務分析
    Ultra Electronics 3Phoenix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ultra Electronics 3Phoenix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Linde plc (LIN):企業の財務・戦略的SWOT分析
    Linde plc (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆